Dean Moss

UDG Healthcare Plc engages in the supply and distribution of pharmaceutical and medical products. It operates through the following segments: Ashfield, Sharp, and Aquilant. The Ashfield segment provides commercialization services for the pharmaceutical and healthcare industry. The Sharp segment offers contract packaging and clinical trial packaging services. The Aquilant segment involves. outsourced sales, marketing, distribution, and engineering services to the medical and scientific sectors. The company was founded in 1948 and is headquartered in Dublin, Ireland.

Binax, Inc. develops, manufactures, and markets point-of-care diagnostic tools. Its products include Filariasis and Legionella Urinary Antigen Tests. The company was founded in 1986 by Roger N. Piasio and Myron C. Hamer and is headquartered in Scarborough, ME

Part of Abbott Laboratories, Amrad ICT is an Australian company that manufactures point-of-care diagnostic tests. The company is based in Sydney, Australia. Amrad ICT was acquired by Binax, Inc. /Old/ from CSL Innovation Pty Ltd. on September 15, 2000.

Part of Merck KGaA, AMRAD Biotech is an Australian company that develops biotechnology reagents and antibodies. The company is based in Boronia, Australia. AMRAD Biotech was acquired by CHEMICON International, Inc. from CSL Innovation Pty Ltd. on December 08, 1999 for $8.92 million.

UniQuest Pty Ltd. operates as a commercialization company of The University of Queensland. It specializes in industry-university collaborations, global technology transfer, and provide access to UQ's world-class expertise, intellectual property, and facilities. The company was founded in July 1984 and is headquartered in Brisbane, Australia.

Princess Alexandra Hospital NHS Trust provides hospital services. The non-profit company is based in Essex, UK. Lance McCarthy has been the CEO of the British company since 2017.

Neurotide is a spin-off company from The University of Queensland's commercial arm, UniQuest Pty Ltd. The company's research is led by UQ's Professor Istvan Toth and Dr Joanne Blanchfield, who are creating an oral pharmaceutical for pain. They are demonstrating that the drug can relieve pain in vivo. If this research is successful, the company will move towards human trials. Investors are sought to help them continue development. They hope to access the international market for pain drugs, and are particularly targeting the neuropathic pain market.

QIMR Berghofer Medical Research Institute is a successful medical research institute in Australia that was established 75 years ago by the Queensland government. QIMR Berghofer is based in Herston, Australia. The institute focuses on improving health by developing new diagnostics, better treatments, and prevention strategies for cancer, infectious diseases, mental health, and chronic disorders. QIMR Berghofer collaborates with clinicians and other research institutes and has an active program for patenting and commercializing technologies. The institute is home to approximately 1000 scientists, students, and support staff. It has made significant contributions to the field of inflammation biology, chronic disorders, and the development of vaccines for diseases such as Zika, Ebola, and COVID-19.